An Anti-Influenza Virus Antibody Inhibits Viral Infection by Reducing Nucleus Entry of Influenza Nucleoprotein

To date, four main mechanisms mediating inhibition of influenza infection by anti-hemagglutinin antibodies have been reported. Anti-globular-head-domain antibodies block either influenza virus receptor binding to the host cell or progeny virion release from the host cell. Anti-stem region antibodies hinder the membrane fusion process or induce antibody-dependent cytotoxicity to infected cells. In this study we identified a human monoclonal IgG1 antibody (CT302), which does not inhibit both the receptor binding and the membrane fusion process but efficiently reduced the nucleus entry of viral nucleoprotein suggesting a novel inhibition mechanism of viral infection by antibody. This antibody binds to the subtype-H3 hemagglutinin globular head domain of group-2 influenza viruses circulating throughout the population between 1997 and 2007.

[1]  Indranil Banerjee,et al.  Influenza A virus uses the aggresome processing machinery for host cell entry , 2014, Science.

[2]  V. Brusic,et al.  Large-Scale Analysis of B-Cell Epitopes on Influenza Virus Hemagglutinin – Implications for Cross-Reactivity of Neutralizing Antibodies , 2014, Front. Immunol..

[3]  P. Palese,et al.  Broadly neutralizing hemagglutinin stalk–specific antibodies require FcγR interactions for protection against influenza virus in vivo , 2014, Nature Medicine.

[4]  Antoine M. van Oijen,et al.  Mechanisms of Hemagglutinin Targeted Influenza Virus Neutralization , 2013, PloS one.

[5]  I. Banerjee,et al.  High-Content Analysis of Sequential Events during the Early Phase of Influenza A Virus Infection , 2013, PloS one.

[6]  James E. Crowe,et al.  Influenza Human Monoclonal Antibody 1F1 Interacts with Three Major Antigenic Sites and Residues Mediating Human Receptor Specificity in H1N1 Viruses , 2012, PLoS pathogens.

[7]  N. S. Laursen,et al.  Highly Conserved Protective Epitopes on Influenza B Viruses , 2012, Science.

[8]  I. Wilson,et al.  Broadly neutralizing antibodies against influenza virus and prospects for universal therapies. , 2012, Current opinion in virology.

[9]  R. Albrecht,et al.  Influenza Viruses Expressing Chimeric Hemagglutinins: Globular Head and Stalk Domains Derived from Different Subtypes , 2012, Journal of Virology.

[10]  A. Vincent,et al.  A novel monoclonal antibody effective against lethal challenge with swine-lineage and 2009 pandemic H1N1 influenza viruses in mice. , 2011, Virology.

[11]  J. Skehel,et al.  A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins , 2011, Science.

[12]  Martin H. Koldijk,et al.  A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses , 2011, Science.

[13]  A. García-Sastre,et al.  Influenza A viruses: new research developments , 2011, Nature Reviews Microbiology.

[14]  Shien Tsai,et al.  Production and Characterization of Chimeric Monoclonal Antibodies against Burkholderia pseudomallei and B. mallei Using the DHFR Expression System , 2011, PloS one.

[15]  Y. Iba,et al.  Localization of epitopes recognized by monoclonal antibodies that neutralized the H3N2 influenza viruses in man , 2011, The Journal of general virology.

[16]  Steven J. Gamblin,et al.  Influenza Hemagglutinin and Neuraminidase Membrane Glycoproteins , 2010, The Journal of Biological Chemistry.

[17]  J. Klingström,et al.  An Antibody against a Novel and Conserved Epitope in the Hemagglutinin 1 Subunit Neutralizes Numerous H5N1 Influenza Viruses , 2010, Journal of Virology.

[18]  John Steel,et al.  Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain , 2010, mBio.

[19]  T. Yasunaga,et al.  Highly conserved sequences for human neutralization epitope on hemagglutinin of influenza A viruses H3N2, H1N1 and H5N1: Implication for human monoclonal antibody recognition. , 2010, Biochemical and biophysical research communications.

[20]  R. Hai,et al.  Broadly Protective Monoclonal Antibodies against H3 Influenza Viruses following Sequential Immunization with Different Hemagglutinins , 2010, PLoS pathogens.

[21]  Gira Bhabha,et al.  Antibody Recognition of a Highly Conserved Influenza Virus Epitope , 2009, Science.

[22]  Y. Matsuoka,et al.  Development of Epitope-Blocking ELISA for Universal Detection of Antibodies to Human H5N1 Influenza Viruses , 2009, PloS one.

[23]  W. Hong,et al.  Comparing the antibody responses against recombinant hemagglutinin proteins of avian influenza A (H5N1) virus expressed in insect cells and bacteria , 2008, Journal of medical virology.

[24]  A. Nishizono,et al.  Identification of a human monoclonal Fab with neutralizing activity against H3N2 influenza A strain from a newly constructed human Fab library , 2008, Microbiology and immunology.

[25]  A. Osterhaus,et al.  Cross-Protection against Lethal H5N1 Challenge in Ferrets with an Adjuvanted Pandemic Influenza Vaccine , 2008, PloS one.

[26]  T. Hope,et al.  Proteasome inhibitors uncouple rhesus TRIM5alpha restriction of HIV-1 reverse transcription and infection. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[27]  R. Rappaport,et al.  Development of an improved microneutralization assay for respiratory syncytial virus by automated plaque counting using imaging analysis , 2005, Virology Journal.

[28]  P. Palese,et al.  Influenza: old and new threats , 2004, Nature Medicine.

[29]  G. Air,et al.  Antibody Epitopes on the Neuraminidase of a Recent H3N2 Influenza Virus (A/Memphis/31/98) , 2002, Journal of Virology.

[30]  J. Skehel,et al.  An antibody that prevents the hemagglutinin low pH fusogenic transition. , 2002, Virology.

[31]  Carlos F. Barbas,et al.  Phage display: a Laboratory manual , 2014 .

[32]  G. Air,et al.  Influenza virus infection of desialylated cells. , 2000, Glycobiology.

[33]  Limburg,et al.  Characterization of monoclonal antibodies to proteinase 3 (PR3) as candidate tools for epitope mapping of human anti‐PR3 autoantibodies , 1999, Clinical and experimental immunology.

[34]  Damien Fleury,et al.  A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site , 1999, Nature Structural Biology.

[35]  S. Loefas,et al.  Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors. , 1991, Analytical biochemistry.

[36]  J. Hierholzer,et al.  Microneutralization test for respiratory syncytial virus based on an enzyme immunoassay , 1985, Journal of clinical microbiology.

[37]  W. G. Laver,et al.  Inhibition of Virus Release by Antibodies to Surface Antigens of Influenza Viruses , 1974, Journal of virology.

[38]  R. Hughes,et al.  Cold Spring Harbor , 2014 .

[39]  G. Towers,et al.  Inhibition of retroviral replication by members of the TRIM protein family. , 2013, Current topics in microbiology and immunology.

[40]  H. Jin,et al.  A variant of MDCK cell line which restricted growth of influenza viruses mainly through suppression of viral primary transcription , 2005, Archives of Virology.

[41]  J. Skehel,et al.  Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. , 2000, Annual review of biochemistry.